Medico Intercontinental Ltd (BSE: 539938) is an Ahmedabad, Gujarat-based company in the Health Care Distributors industry. With a market capitalisation of ₹25 Cr, it ranks #4,279 by market cap among the 6,197 Indian listed companies on FinBizNet, and #5 of 11 in Health Care Distributors. At ₹24.85 (as of 16 Nov 2026), the share price is 42.2% below its 52-week high of ₹43.00 and 20.6% above its 52-week low of ₹20.61. The share price is down 31.5% over one year and down 11.4% over three months.
| Current Price | ₹24.85 |
|---|---|
| Market Cap | ₹25 Cr |
| BSE Code | 539938 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -27.14% |
| Return on Assets | -1.03% |
| 52-Week Range | ₹20.61 – ₹43.00 |
| 1-Year Price Change | -31.5% |
| 3-Month Price Change | -11.4% |
| Beta (1Y) | 0.3 |
| Dividend Yield | 0.00% |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.medicointercontinental.com |
| Revenue | ₹14 Cr |
|---|---|
| Net Profit | ₹1 Cr |
| Net Margin | 4.3% |
| EPS (Basic) | ₹0.61 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Medico Intercontinental Ltd reported revenue of ₹14 Cr in Q1 FY27, up 6.4% from ₹13 Cr in Q1 FY26 and down 9.4% from ₹16 Cr in Q4 FY26. It posted a net profit of ₹1 Cr for the quarter, against a net profit of ₹1 Cr in Q1 FY26 (up 8.9%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹12 Cr (Q2 FY26) to ₹16 Cr (Q4 FY26). The company was profitable in each of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹14 Cr | ₹1 Cr | 4.3% |
| Q4 FY26 | ₹16 Cr | ₹0 Cr | 2.7% |
| Q3 FY26 | ₹13 Cr | ₹1 Cr | 4.8% |
| Q2 FY26 | ₹12 Cr | ₹1 Cr | 4.8% |
| Q1 FY26 | ₹13 Cr | ₹1 Cr | 4.2% |
| Q4 FY25 | ₹15 Cr | ₹1 Cr | 3.5% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 61.38% of Medico Intercontinental Ltd's shares as of Mar 2026, against 63.79% in Mar 2025 (−2.41 percentage points). Delivery averaged 89.3% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Medico Intercontinental Limited engages in the trading of pharmaceutical products. It offers products in the gastro, uro, nutrition, cosmetology, and other areas, as well as provides health devices and hospital related products. The company also provides general and derma range products in various forms, such as tablets, soft gelatine, capsules, dental, ointments, powders and sprays, liquids, ayurvedics, injectables, dry syrup, suspension, drops, infusion, soap, and nutritional; and medical FTF products, including antiseptic liquid, multipurpose cleaner, hand wash, immunity booster, and N95 face mask products, liquid, gel, and spray hand sanitizer, as well as eye drops. The company was formerly known as Intercontinental Leasing & Finance Company Limited and changed its name to Medico Intercontinental Limited in December 2018. Medico Intercontinental Limited was incorporated in 1984 and is based in Ahmedabad, India.
1. Trading-This segment engages in the trading of pharmaceutical products. 2. Finance-This segment financing services. 3. Unallocated Provision for Taxes / Deferred Tax-0 4. Other Non-Allocable Income-0
1. Trading-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Trimurthi Ltd | ₹197 Cr | 57.6 | 7.99% | — | +33.3% |
| Achyut Healthcare Ltd | ₹191 Cr | 609.2 | 0.95% | — | +39.7% |
| Vaidya Sane Ayurved Laboratories | ₹148 Cr | — | 13.40% | — | -46.6% |
| Balaxi Pharmaceuticals Ltd | ₹125 Cr | 92.2 | 0.59% | ₹81 Cr | -44.5% |
| Medico Intercontinental Ltd | ₹25 Cr | n/m | -27.14% | ₹14 Cr | -31.5% |
| Zenlabs Ethica Ltd | ₹19 Cr | n/m | -20.44% | — | -12.5% |
| Rubra Medicaments Ltd. | ₹18 Cr | 12.2 | 12.67% | — | -53.2% |
| Nexus Surgical & Medicare Ltd | ₹15 Cr | 20 | 51.41% | — | +76.5% |
| Brawn Biotech Ltd. | ₹7 Cr | 7 | 24.43% | — | +9.4% |
Listed by market capitalisation. Ratios are shown for context only.
Medico Intercontinental Ltd is trading at ₹24.85, with a market capitalisation of ₹25 Cr.
Medico Intercontinental Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).
Medico Intercontinental Ltd has a return on equity of -27.14%.
Medico Intercontinental Ltd is listed on the BSE under the scrip code 539938.
Medico Intercontinental Ltd's share price is down 31.5% over one year and down 11.4% over three months. Its 52-week range is ₹20.61 to ₹43.00.
In Q1 FY27, Medico Intercontinental Ltd reported revenue of ₹14 Cr and net profit of ₹1 Cr, with basic EPS of ₹0.61 (standalone, parsed from the company's exchange filing).
Medico Intercontinental Ltd reported revenue of ₹14 Cr in Q1 FY27, up 6.4% from ₹13 Cr in Q1 FY26 and down 9.4% from ₹16 Cr in Q4 FY26.
Promoters held 61.38% of Medico Intercontinental Ltd's shares as of Mar 2026, against 63.79% in Mar 2025 (−2.41 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.